H.R.es93 - Providing for consideration of the bill (H.R. 27) to amend the Controlled Substances Act with respect to the scheduling of fentanyl-related substances, and for other purposes. (119th Congress)
Summary
H.Res.93 is a resolution providing for the consideration of H.R.27, a bill to amend the Controlled Substances Act concerning the scheduling of fentanyl-related substances. The resolution outlines the procedures for debating and amending the bill in the House of Representatives.
It waives points of order against the bill and specifies the amendments to be considered. The resolution also sets time limits for debate and allows for a motion to recommit.
Expected Effects
If adopted, H.Res.93 will allow the House to proceed with debating and potentially passing H.R.27, which aims to address the opioid crisis by modifying the scheduling of fentanyl-related substances under the Controlled Substances Act. This could lead to changes in how law enforcement and the justice system handle cases involving these substances.
The specific impact will depend on the content of H.R.27 and any amendments that are adopted.
Potential Benefits
- Could lead to more effective law enforcement efforts against fentanyl trafficking.
- May reduce the availability of fentanyl-related substances and decrease overdose deaths.
- Streamlines the legislative process for addressing the opioid crisis.
- Allows for focused debate and consideration of specific amendments.
- Potentially improves public safety and community well-being.
Potential Disadvantages
- May lead to unintended consequences related to the scheduling of substances.
- Could disproportionately affect certain communities or individuals.
- The waiver of points of order may limit scrutiny of the bill.
- The expedited process may not allow for full consideration of all perspectives.
- Potential for increased penalties without addressing underlying issues of addiction.
Constitutional Alignment
The resolution itself is procedurally aligned with the Constitution, particularly Article I, Section 5, which grants each house of Congress the power to determine the rules of its proceedings. The underlying bill, H.R. 27, amending the Controlled Substances Act, falls under the commerce clause (Article I, Section 8), which gives Congress the power to regulate interstate commerce, including the regulation of drugs.
However, the specific provisions of H.R. 27 would need to be analyzed separately to ensure they do not infringe upon individual rights or other constitutional protections. The waiver of points of order could potentially bypass some procedural safeguards, but this is generally within the purview of the House's internal rules.
Impact Assessment: Things You Care About ⓘ
This action has been evaluated across 19 key areas that matter to you. Scores range from 1 (highly disadvantageous) to 5 (highly beneficial).